Steris PLC (N:STE)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: Block a Riverside IV
70 Sir John Rogerson's Quay
DUBLIN 2
Tel: 1-440-3927245
Website: https://www.steris.com
IR: See website
<
Key People
Mohsen M. Sohi
Independent Chairman of the Board
Walter M. Rosebrough
President, Chief Executive Officer, Director
Michael J. Tokich
Chief Financial Officer, Senior Vice President
Daniel A. Carestio
Chief Operating Officer, Senior Vice President
J. Adam Zangerle
Senior Vice President, General Counsel, Secretary
Renato G. Tamaro
Vice President and Corporate Treasurer
Cary L. Majors
Vice President - North America Commercial Operations
   
Business Overview
Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It's Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.
Financial Overview
For the fiscal year ended 31 March 2020, Steris PLC revenues increased 9% to $3.03B. Net income increased 34% to $407.6M. Revenues reflect Healthcare Products segment increase of 6% to $1.42B, Applied Sterilization Technologies segment increase of 13% to $627.1M, Health speciality services segment increase of 10% to $563.6M, United States segment increase of 12% to $2.21B, Other Foreign segment increase of 1% to $755.4M.
Employees: 13,000 as of Mar 31, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $13,587M as of Mar 31, 2020
Annual revenue (TTM): $3,031M as of Mar 31, 2020
EBITDA (TTM): $751.67M as of Mar 31, 2020
Net annual income (TTM): $407.61M as of Mar 31, 2020
Free cash flow (TTM): $253.01M as of Mar 31, 2020
Net Debt Last Fiscal Year: $830.94M as of Mar 31, 2020
Shares outstanding: 84,951,399 as of May 29, 2020
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization